Cairo – Mubasher: Minapharm Pharmaceuticals has announced the closure of an EGP 95.52 million deal to buy a 15.76% stake in its subsidiary, Minapharm Probiogen from Triquetra B.V.
The Egypt-listed company has acquired 4,871 of Minapharm Probiogen’s shares, according to a bourse statement.
Following the deal, Minapharm Pharmaceuticals’ stake in the subsidiary will be increased to 75.01% from 59.25%.
